HF
IRON icon

HRT Financial’s Disc Medicine IRON Stock Holding History

HRT Financial’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64M Buy
+90,822
New +$6.24M 0.01% 985
2025
Q1 		– Sell
-10,358
Closed -$656K – 2932
2024
Q4 		$656K Buy
+10,358
New +$599K ﹤0.01% 1307
2024
Q1 		– Sell
-16,870
Closed -$974K – 2673
2023
Q4 		$974K Buy
+16,870
New +$864K 0.01% 998
2021
Q4 		– Sell
-1,385
Closed -$167K – 3605
2021
Q3 		$167K Buy
+1,385
New +$189K ﹤0.01% 2753

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's IRON Position: Q2 2026 in Review

HRT Financial opened a new position in Disc Medicine (IRON) in Q2 2026: 90,822 shares worth $6.64M. The stake represents 0.01% of the portfolio and ranks #985 among its holdings. This is a return to the name: HRT Financial previously reported a position in IRON as recently as Q4 2024.

HRT Financial first reported a position in IRON in Q3 2021 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • HRT Financial held 90,822 shares of Disc Medicine worth $6.64M as of Q2 2026.
  • Disc Medicine was a new HRT Financial position in Q2 2026.
  • Disc Medicine made up 0.01% of HRT Financial's portfolio in Q2 2026, its #985 holding.
  • HRT Financial first reported a position in Disc Medicine in Q3 2021 and has held it in 4 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.